Associated Papers
Somatic driver mutation prevalence in 1844 prostate cancers identifies ZNRF3 loss as a predictor of metastatic relapse.
Fraser M et al.
Nature Communications, 2021
34716314 (PubMed )
Supplement: 41467_2021_26489_MOESM3_ESM.zip › Supplementary_Data › NatComms-Rev2-DataS06.xlsx › Driversv12-TableS11
Select a paper to view details